<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">nature publishing group N-terminal B-type natriuretic peptide urinary concentrations and retinopathy of prematurity</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Christoph</forename><surname>Bührer</surname></persName>
							<email>christoph.buehrer@charite.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Neonatology</orgName>
								<orgName type="institution">Charité Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ömer</forename><surname>Erdeve</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Neonatology</orgName>
								<orgName type="institution">Zekai Tahir Burak Maternity Hospital</orgName>
								<address>
									<settlement>Ankara</settlement>
									<country key="TR">Turkey</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="department" key="dep1">Department of Neonatology</orgName>
								<orgName type="department" key="dep2">(Ö.E.); Intensive Care and Department of Pediatric Surgery</orgName>
								<orgName type="department" key="dep3">Erasmus Medical Center</orgName>
								<orgName type="institution">Ankara University School of Medicine</orgName>
								<address>
									<settlement>Ankara</settlement>
									<country key="TR">Turkey</country>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="institution">Sophia Children&apos;s Hospital</orgName>
								<address>
									<settlement>Rotterdam</settlement>
									<country>The Netherlands (K.A.</country>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<orgName type="institution">Etlik Zübeyde Hanım Women&apos;s Diseases Education and Research Hospital</orgName>
								<address>
									<settlement>Ankara</settlement>
									<country key="TR">Turkey</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anton</forename><surname>Van Kaam</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Neonatology</orgName>
								<orgName type="institution" key="instit1">Emma Children&apos;s Hospital</orgName>
								<orgName type="institution" key="instit2">Academic Medical Center Amsterdam</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Angelika</forename><surname>Berger</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Pediatrics and Adolescent Medicine</orgName>
								<orgName type="institution">Medical University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Evelyn</forename><surname>Lechner</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department of Neonatology</orgName>
								<orgName type="institution">Kepler University Medical Center</orgName>
								<address>
									<settlement>Linz</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Benjamin</forename><surname>Bar-Oz</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Department of Neonatology</orgName>
								<orgName type="institution">Hadassah Medical Center</orgName>
								<address>
									<settlement>Jerusalem</settlement>
									<country key="IL">Israel</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Karel</forename><surname>Allegaert</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of Development and Regeneration</orgName>
								<orgName type="institution">KU Leuven</orgName>
								<address>
									<settlement>Leuven</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="department" key="dep1">Department of Neonatology</orgName>
								<orgName type="department" key="dep2">(Ö.E.); Intensive Care and Department of Pediatric Surgery</orgName>
								<orgName type="department" key="dep3">Erasmus Medical Center</orgName>
								<orgName type="institution">Ankara University School of Medicine</orgName>
								<address>
									<settlement>Ankara</settlement>
									<country key="TR">Turkey</country>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="institution">Sophia Children&apos;s Hospital</orgName>
								<address>
									<settlement>Rotterdam</settlement>
									<country>The Netherlands (K.A.</country>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<orgName type="institution">Etlik Zübeyde Hanım Women&apos;s Diseases Education and Research Hospital</orgName>
								<address>
									<settlement>Ankara</settlement>
									<country key="TR">Turkey</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Tom</forename><surname>Stiris</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Department of Neonatal Intensive Care</orgName>
								<orgName type="institution">Oslo University Hospital</orgName>
								<address>
									<settlement>Oslo</settlement>
									<country key="NO">Norway</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">İstemi</forename><forename type="middle">Han</forename><surname>Çelik</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Neonatology</orgName>
								<orgName type="institution">Zekai Tahir Burak Maternity Hospital</orgName>
								<address>
									<settlement>Ankara</settlement>
									<country key="TR">Turkey</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="department" key="dep1">Department of Neonatology</orgName>
								<orgName type="department" key="dep2">(Ö.E.); Intensive Care and Department of Pediatric Surgery</orgName>
								<orgName type="department" key="dep3">Erasmus Medical Center</orgName>
								<orgName type="institution">Ankara University School of Medicine</orgName>
								<address>
									<settlement>Ankara</settlement>
									<country key="TR">Turkey</country>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="institution">Sophia Children&apos;s Hospital</orgName>
								<address>
									<settlement>Rotterdam</settlement>
									<country>The Netherlands (K.A.</country>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<orgName type="institution">Etlik Zübeyde Hanım Women&apos;s Diseases Education and Research Hospital</orgName>
								<address>
									<settlement>Ankara</settlement>
									<country key="TR">Turkey</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Janet</forename><surname>Berrington</surname></persName>
							<affiliation key="aff8">
								<orgName type="department">Newcastle Neonatal Service</orgName>
								<orgName type="institution" key="instit1">Royal Victoria Infirmary</orgName>
								<orgName type="institution" key="instit2">Newcastle upon Tyne</orgName>
								<address>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">nature publishing group N-terminal B-type natriuretic peptide urinary concentrations and retinopathy of prematurity</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">40FD239A8DF6CF801CA4A7B5B0ECD4B2</idno>
					<idno type="DOI">10.1038/pr.2017.179</idno>
					<note type="submission">Received 2 May 2017; accepted 26 June 2017; advance online publication 16 August 2017.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:28+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>DOL, day of life</term>
					<term>NTproBNP, N-terminal B-type natriuretic peptide</term>
					<term>ROC, receiver operating characteristics</term>
					<term>ROP, retinopathy of prematurity</term>
					<term>UNBCR, urinary NTproBNP/creatinine ratio. Numbers represent median and interquartile range</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Further members of the REDEXAM study group are listed above References.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>BACKGROUND: To validate the findings of a single-center pilot study showing elevated urinary N-terminal B-type natriuretic peptide (NTproBNP) concentrations in preterm infants subsequently developing severe retinopathy of prematurity (ROP) in a multicenter setting across eight European and Middle East countries.</s><s>METHODS: Prospective observational study in 967 preterm infants o30 weeks' gestational age assessing the capacity of urinary NTproBNP on days of life (DOLs) 14 and 28 to predict ROP requiring treatment.</s><s>RESULTS: Urinary NTproBNP concentrations were markedly elevated in infants who developed ROP requiring treatment (n = 94) compared with survivors without ROP treatment (n = 837), at both time points (median (interquartile range) DOL14: 8,950 (1,925-23,783) vs. <ref type="bibr">3,083 (1,193-17,393)</ref> vs. 816 (290-3,078) pg/ml, Po0.001) and DOL28 <ref type="bibr">(2,203 (611-4,063)</ref> vs. 1,671 (254-11,340) vs. 408 (162-1,126) pg/ml, Po0.001).</s><s>C-statistic of NTproBNP for treated ROP or death was 0.731 (95% confidence interval 0.654-0.774)</s><s>for DOL14 and 0.683 (0.622-0.745) for DOL28 (Po0.001).</s><s>Threshold scores were calculated, potentially enabling around 20% of infants with low NTproBNP scores never to be screened with ophthalmoscopy.</s><s>CONCLUSION: There is a strong association between early urinary NTproBNP and subsequent ROP development, which can be used to further refine subgroups of patients with high or low risk of severe ROP.</s><s>R etinopathy of prematurity (ROP) is responsible for a large proportion of potentially preventable childhood blindness worldwide, with approximately two-thirds of preterm infants displaying ROP-mediated visual impairment being born in middle-income countries (1).</s><s>This proliferative disorder of blood vessels in the immature retina develops gradually after birth.</s><s>Therefore, a window exists to screen, detect, and treat in a timely manner where indicated.</s><s>Screening by indirect ophthalmoscopy is supposed to start at a corrected gestational age of 31 weeks and a chronological age of 44 weeks.</s><s>Numbers of ophthalmologists who are able and willing to perform ROP screening are often limited by liability concerns, reimbursement issues, and lack of training opportunities both in high-and middle-income countries <ref type="bibr" target="#b4">(2)</ref><ref type="bibr" target="#b5">(3)</ref><ref type="bibr" target="#b6">(4)</ref>.</s><s>Besides being an expensive and limited resource, ophthalmoscopy is distressing to families to observe and potentially destabilizing infants.</s><s>Adverse events related to the procedure or eye drops used include life-threatening apnea, bradycardia, hypoxia, tachycardia, emesis, and retinal hemorrhages (5-10), whereas the pain and stress response to ophthalmoscopy is poorly blunted by oral sucrose <ref type="bibr" target="#b13">(11)</ref>.</s></p><p><s>Although a considerable proportion of very preterm infants develop some degree of ROP, only a small fraction progresses to severe ROP requiring treatment (laser surgery or intravitreal pharmacological therapy).</s><s>Thus, biomarkers that define infants at high or low risk of ROP requiring intervention would have wide implications for many infants, families, and health economies.</s><s>Such biomarkers would ideally have high sensitivity and specificity and should be used on noninvasive samples by local laboratories.</s></p><p><s>In response to increased preload or afterload, cardiac myocytes release B-type natriuretic peptide (BNP) into the circulation.</s><s>BNP acts on the heart (accelerated myocardial relaxation), the vasculature (vasodilation), and the kidneys (natriuresis).</s><s>It is generated by proteolytic cleavage of a precursor protein, yielding the biologically active BNP and an inert N-terminal fragment, N-terminal B-type natriuretic peptide (NTproBNP, amino acids 1-76).</s><s>Measuring NTproBNP concentrations is widely being used for the assessment of cardiac failure in adults, children, and neonates <ref type="bibr">(12)</ref><ref type="bibr" target="#b15">(13)</ref><ref type="bibr">(14)</ref>.</s><s>NTproBNP concentrations in blood parallel those determined in urine <ref type="bibr" target="#b17">(15)</ref>.</s><s>In preterm infants, elevated NTproBNP concentrations measured in blood or urine have been shown to herald incipient bronchopulmonary dysplasia and are indicative of a hemodynamically significant patent ductus arteriosus <ref type="bibr" target="#b18">(16)</ref>.</s></p><p><s>In a single-center pilot study, we found that urinary NTproBNP/creatinine ratios (UNBCR) during the first month were significantly elevated in preterm infants who developed severe ROP, compared with controls <ref type="bibr" target="#b19">(17)</ref>.</s><s>To further assess the predictive power of urinary NTproBNP concentrations and UNBCR during the first month of life to allow early identification of infants at high or low risk of severe ROP, we conducted a prospective observational study (REDEXAM, REDucing Eye EXAMinations in preterm infants) in neonatal intensive units in eight European and Middle East countries.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study Setting</head><p><s>Neonatal intensive care units are located in the United Kingdom, The Netherlands, Belgium, Norway, Germany, Austria, Turkey, and Israel after approval of the ethical committees of each site.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients and Measurements</head><p><s>Preterm infants with a gestational age below 30 who completed weeks alive at 10 days were eligible (recruitment periods varied by site).</s><s>After written informed parental consent, spot urine samples were collected on DOL (day of life) 14 and DOL28 (or as close as possible).</s><s>Urine was collected by each center by their usual method, and included using cotton wool balls or pads in the nappy, bags, or clean catches by staff or parents at routine nappy changes, and stored at − 80 °C until analysis.</s><s>Urinary NTproBNP concentrations were determined at each site in batches by standard hospital laboratoryautomated commercial chemiluminescent sandwich immunoassays (Roche Modula P E170 run on a cobas e 411 analyzer, Roche Diagnostics International, Rotkreuz, Switzerland) as described previously <ref type="bibr" target="#b19">(17)</ref>, whereas urinary creatinine concentrations were determined enzymatically or by the Jaffé method.</s><s>Further data recorded were maternal age and the infant's weight on DOL14 and DOL28.</s><s>Proportional weight gain was calculated by dividing the gain of the infant's weight since birth on DOL14 or DOL28 by birth weight.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ROP Outcomes</head><p><s>ROP-screening examinations using serial binocular indirect ophthalmoscopy were carried out by experienced local ophthalmologists according to local and national guidelines and were not influenced in any way by this study.</s><s>The ophthalmologists staged ROP according to the International Classification of Retinopathy of Prematurity <ref type="bibr" target="#b20">(18)</ref> and allocated treatment according to the Early Treatment for Retinopathy of Prematurity criteria <ref type="bibr" target="#b21">(19)</ref>.</s><s>They were unaware of urinary NTproBNP concentrations.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical Analysis</head><p><s>NTproBNP results for infants with known ROP outcome and at least one urinary NTproBNP concentration measured were analyzed using SPSS 23.0 (SPSS, Chicago, IL).</s><s>As NTproBNP results and other variables lacked a normal distribution, data are presented as median and interquartile range.</s><s>Dichotomous values are presented as numbers (percentages).</s><s>We assessed the strength of association between continuous variables by Spearman rank order coefficients.</s><s>Differences in the distribution of continuous variables were assessed by the Mann-Whitney U-test (for two groups) or the Kruskal-Wallis test (more than two groups, followed by post hoc analysis employing the Mann-Whitney U-test).</s><s>For paired samples, the Wilcoxon test was used.</s><s>Continuous variables found to be significantly associated with a dichotomous variable by univariate analysis were entered into multivariate linear regression analysis with backward elimination for P40.1.</s><s>Predictive values were estimated by the areas under receiver operating characteristic (ROC) curves (C-statistic).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patient Characteristics</head><p><s>A total of 1,000 infants were recruited between January 2012 and July 2015 (exact recruitment periods varied by site).</s><s>After exclusion of 33 infants (gestational age ≥ 30 weeks, n = 13; failed urine collection both DOL14 and DOL28, n = 20), 967 infants were included in the final analysis <ref type="bibr">(</ref>  <ref type="bibr">(31.4 (19.</ref>0-41.9)% vs. 36.1 (24.8-48.1)%,</s><s>P = 0.007) but not between birth and DOL14 (P = 0.080).</s><s>The sex ratio, multiple vs. singleton pregnancy, and maternal age did not differ between survivors with or without ROP treatment (P40.1).</s><s>Patient characteristics by country are given in Table <ref type="table" target="#tab_1">1</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Urinary NTproBNP Concentrations and UNBCR</head><p><s>Baseline data.</s><s>Urinary NTproBNP concentrations declined from median 992 (330-4,082) pg/ml on DOL14 to 470 (170-1,465) pg/ml on DOL28 (Po0.001).</s><s>The same pattern was observed for UNBCR (DOL14: 92 (30-413), DOL28: 39 (15-137) pg/ml, Po0.001).</s><s>Urinary NTproBNP concentrations and UNBCR were slightly higher in boys than in girls on DOL14 (NTproBNP: 1,146 (387-4,436) vs. 801 (272-3,527) pg/ml, P = 0.010; UNBCR: 103 (36-441) vs. 79 (24-386) × 10 − 4 , P = 0.018) but not on DOL28 of life (NTproBNP: 468 (197-1,575) vs. 438 (151-1,329) pg/ml, P = 0.142; UNBCR: 41(17-122) vs. 37 (12-137), P = 0.195).</s></p><p><s>Associations with survival, ROP stages, and ROP treatment.</s><s>Urinary NTproBNP concentrations and UNBCR were markedly elevated in infants who subsequently died (n = 36) and in survivors with severe ROP requiring intervention (laser or intravitreal therapy; n = 94), as compared with survivors without ROP intervention (n = 837; Table <ref type="table" target="#tab_2">2</ref>).</s></p><p><s>Survivors with no/little ROP (stage 0 or 1) had lower urinary NTproBNP concentrations and UNBCRs than infants with ROP stage 2 or ROP stage 3 (Table <ref type="table" target="#tab_3">3</ref>).</s><s>There was no significant difference between infants with no ROP and infants with ROP stage 1.</s><s>In contrast, median NTproBNP levels were increased almost threefold in infants with ROP stage 2 and approximately fivefold in infants with ROP stage 3, as compared with the levels in infants without ROP.</s></p><p><s>Prediction of survival without treated ROP.</s><s>The capacity of NTproBNP and UNBCR to predict survival without ROP treatment was assessed by the areas under ROC curves (Table <ref type="table" target="#tab_4">4</ref>).</s><s>ROC areas of NTproBNP or UNBCR to predict survival without ROP treatment were larger on DOL14 than on DOL28, whereas those of UNBCR were only slightly larger than plain NTproBNP at both time points.</s><s>For urinary NTproBNP DOL14, the areas under the ROC curve to predict survival without ROP treatment were very high in participating units in Turkey (0.872), Austria (0.818), and Germany (0.817), high in Belgium (0.780), Israel (0.767), and the Netherlands (0.736) but lower in the UK (0.685) and not significantly different from chance in Norway (0.432).</s></p><p><s>The three variables that differed significantly between infants who did and those who did not survive without ROP treatment and that were known on DOL14 (gestational age, birth weight, and NTproBNP DOL14) were entered into multivariate linear regression analyses aimed at survival without ROP treatment as dependent variable and using backward elimination if P40.1.</s><s>This was repeated for the five variables known on DOL28 (gestational age, birth weight, NTproBNP DOL14, NTproBNP DOL28, and proportional weight gain DOL28).</s><s>All factors were retained in the final equations.</s><s>Linear coefficients (ß) were then applied as weighted values to create scores predictive of survival without ROP treatment.</s><s>These scores were calculated using the formula DOL14 (300 − 0.156 × gestational age (weeks) − 0.118 × birth weight (g)+0.146</s><s>× NTproBNP DOL14 (pg/ml)) and DOL28 (300 − 0.118 × gestational age (weeks) − 0.131 × birth weight (g)+0.067</s><s>× NTproBNP DOL14 (pg/ml)+0.180</s><s>× NTproBNP DOL28 (pg/ml) − 0.110 × proportional weight gain birth to DOL28 (fraction)).</s><s>Scores on DOL14 were 300 (208-636) vs. 656 (341-2,753) vs. 1,539 (464-3,627) in survivors without ROP treatment, survivors with ROP  No infant with a score of DOL14o197, and no infant with a score DOL28o189, developed ROP requiring treatment (thresholds for 100% specificity and 100% positive predictive value for survival without ROP requiring treatment).</s><s>In this cohort, 20.6% of infants were below the DOL14 threshold and 15.3% below the DOL28 threshold ROP, translating into sensitivities of 20.6%/15.3% and negative predictive values of 16.4%/14.3%,</s><s>respectively.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>This multinational study confirms that urinary NTproBNP concentrations during the first month of life are markedly elevated in preterm infants o30 weeks' gestation who, many weeks later, develop severe ROP requiring intervention.</s><s>An even larger elevation of urinary NTproBNP concentrations was observed in infants who subsequently died, linking circulatory stress the first month of life to mortality and morbidity of very preterm infants.</s></p><p><s>Although immaturity and oxygen exposure are pivotal for the development of ROP, the risk of severe ROP is further increased by poor postnatal growth.</s><s>This link is thought to be mediated by low levels of insulin-like growth factor 1 and serves as a base for ROP prediction models such as WINROP <ref type="bibr" target="#b22">(20)</ref> or CHOPROP <ref type="bibr" target="#b23">(21)</ref>.</s><s>Furthermore, severe ROP is more common in infants with conditions that increase myocardial pressure or volume load, such as sepsis <ref type="bibr" target="#b24">(22,</ref><ref type="bibr" target="#b25">23)</ref>, blood transfusions <ref type="bibr" target="#b25">(23,</ref><ref type="bibr" target="#b26">24)</ref>, pulmonary hypertension treated with inhaled nitric oxide <ref type="bibr" target="#b27">(25)</ref>, patent ductus arteriosus <ref type="bibr" target="#b25">(23)</ref>, or inotrope use <ref type="bibr" target="#b24">(22,</ref><ref type="bibr" target="#b28">(26)</ref><ref type="bibr" target="#b29">(27)</ref><ref type="bibr" target="#b30">(28)</ref><ref type="bibr" target="#b31">(29)</ref>.</s><s>Such conditions lead to BNP release and have been associated in several groups of patients with increased NTproBNP <ref type="bibr" target="#b32">(30)</ref><ref type="bibr" target="#b33">(31)</ref><ref type="bibr" target="#b34">(32)</ref><ref type="bibr" target="#b35">(33)</ref>.</s><s>Thus, in addition to slow weight gain and low insulin-like growth factor 1 levels, we hypothesize that circulatory compromise and increased BNP release during the first month of life have a role in ROP development.</s></p><p><s>The potential physiological role of BNP itself in the development of ROP is not yet understood.</s><s>Relative hypoxia triggers BNP secretion from cultured human retinal pigment epithelium <ref type="bibr" target="#b36">(34)</ref>, whereas retinal vessels express receptors for BNP <ref type="bibr" target="#b37">(35)</ref>.</s><s>BNP, however, has so far not been investigated in animal models of oxygen-induced proliferative retinopathy.</s><s>In adults without overt cardiovascular compromise, higher levels of NTproBNP were found to be associated with microvascular damage in the retina <ref type="bibr" target="#b38">(36,</ref><ref type="bibr" target="#b39">37)</ref> and other body parts <ref type="bibr" target="#b38">(36,</ref><ref type="bibr" target="#b40">38)</ref>.</s><s>Thus, it remains up to future experimental investigations to explore and characterize the role of cardiovascular compromise and natriuretic peptides in the pathophysiology of ROP.</s></p><p><s>Previous investigations have used UNBCR rather than plain urinary NTproBNP concentrations to estimate the hemodynamic significance of a patent ductus arteriosus and to assess the risk of ROP or bronchopulmonary dysplasia.</s><s>The power to predict survival without ROP intervention of UNBCR was only marginally better than that of plain NTproBNP, probably reflecting steady-state kidney function at the age of 2-4 weeks in the infants studied.</s><s>Diagnostic patterns of UNBCR and plain NTproBNP were highly similar, limiting the merits of additionally determining creatinine concentrations in urine samples.</s><s>Thus, there is no need to correct for creatinine when using NTproBNP as a screening aid for ROP detection, increasing its potential in low-income settings.</s><s>This study has several limitations, including the lack of standardization of ROP outcomes by central review of ophthalmoloscopic findings.</s><s>Local thresholds for ROP treatment have been shown to differ markedly by country <ref type="bibr" target="#b41">(39)</ref> and may have affected the performance of NTproBNP.</s><s>A fraction of infants with stage 3 ROP in this study were actually not treated.</s><s>However, the approach taken was highly pragmatic, and we have analyzed by treatment received, a clearly defined end point.</s><s>This issue has also large multicenter prospective randomized controlled trials including those investigating the effect of different oxygen target saturations on morbidity and mortality of very preterm infants.</s><s>Participating neonatal intensive care units also had different strategies of fluid management, inotropes, transfusion thresholds, and treatment of a patent ductus arteriosus, which may also affect the relative performance of NTproBNP.</s><s>In our study, NTproBNP concentrations were determined at prespecified time points, not adjusted for potential peaks associated with particular events such as sepsis or surgery.</s><s>Although overall predictive power of NTproBNP measurements was lower than that in the pilot study <ref type="bibr" target="#b19">(17)</ref>, the results also differed markedly by country.</s><s>Urinary NTproBNP DOL14 below 372 pg/ml (a threshold met by more than 26% of all infants studied) was able to identify all infants who did not require ROP treatment in Turkey, Austria, Germany, Belgium, Israel, and the Netherlands, but not in the UK and Norway.</s></p><p><s>NTproBNP and NTproBNP-based scores share the problem of limited generalizability with proportional weight gain <ref type="bibr" target="#b22">(20,</ref><ref type="bibr" target="#b23">21)</ref> or risk factor-based models <ref type="bibr" target="#b24">(22,</ref><ref type="bibr" target="#b26">24)</ref>.</s><s>In contrast to the expectations underlying this multinational endeavor, the results of this study do not allow for a change in current clinical practice in infants o30 weeks.</s><s>However, elevated NTproBNP measured during the first month of life may be helpful to identify infants at greatly increased risk for severe ROP, allowing for early targeted intervention in future trials.</s><s>NTproBNP may also be promising in identifying more mature infants with increased risk of ROP, who currently may be screened only at the request of the attending neonatologist.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONCLUSIONS</head><p><s>Elevated urinary NTproBNP concentrations during the first month of life are strongly associated with subsequent development of severe ROP, whereas low levels are associated with low risk of severe ROP.</s><s>The overlapping ranges of NTproBNP concentrations of infants with and without severe ROP, however, preclude to harness these substantial differences into an algorithm to reduce eye examination in very preterm infants.</s><s>The roles of cardiovascular compromise and natriuretic peptides in the pathophysiology of ROP remain to be determined.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>Associations with patient characteristics.</s><s>Urinary NTproBNP concentrations were inversely related to birth weight (DOL14: R s = − 0.475, DOL28: R s = − 0.428, Po0.001) and gestational age (DOL14: R s = − 0.502, DOL28: R s = − 0.447, Po0.001).</s><s>UNBCR showed similar relationships with birth weight (DOL14: R s = − 0.489, DOL28: R s = − 0.439, Po0.001) and gestational age (DOL14: R s = − 0.501, DOL28: R s = -0.455,</s><s>Po0.001).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head></head><label></label><figDesc><div><p><s>UK, n = 265; Germany, n = 163; Turkey, n = 118; the Netherlands, n = 106; Austria, n = 171; Israel, n = 71; Belgium, n = 49; Norway, n = 24).</s><s>The cohort consisted of 517 boys (53.5%) and 319 multiples (33.0%; 280 twins, 35 triplets, and 4 quadruplets).</s><s>Median (interquartile range) gestational age was 27 3 /7 (26 1 /7 − 28 6 /7) weeks and birth weight was 945 (780-1,165) g.</s><s>The actual age at which urine was collected for DOL14 samples (n = 904) was 14.35 ± 1.37 days (mean ± SD) and 28.33 ± 1.68 days for DOL28 samples (n = 839).</s><s>In all, 36 infants died before discharge.</s><s>Among the survivors, 550 infants were without ROP, 133 with ROP stage 1, 150 with ROP stage 2, and 98 with ROP stage 3. Treatment for ROP was performed in 94 infants (laser ablative surgery, n = 76; intravitreal bevacizumab injections, n = 18).</s><s>Survivors with ROP treatment compared with survivors without ROP treatment had lower gestational age (25 4 / 7 (24 5 / 7 − 26 6 / 7 ) weeks vs. 27 5 / 7 (26 2 / 7 -29 0 / 7 ) weeks, Po0.001), lower birth weight (755 (640-905) g vs. 980 (815-1,180) g, Po0.001), and lower proportional weight gain between birth and DOL28</s></p></div></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>Patients' characteristics by country (median/interquartile range or n/%, respectively)</s></p></div></figDesc><table><row><cell>Country</cell><cell>n</cell><cell>Gestational age (weeks)</cell><cell>Birth weight (g)</cell><cell>Died (n, %)</cell><cell>ROP intervention (n, %)</cell></row><row><cell>Austria</cell><cell>171</cell><cell>26 0 / 7 -28 6 / 7 27 4 / 7</cell><cell>690-1,146 920</cell><cell>6 (3.5%)</cell><cell>4 (2.3%)</cell></row><row><cell>Belgium</cell><cell>49</cell><cell>26 0 / 7 -28 6 / 7 27 3 / 7</cell><cell>863-1,120 980</cell><cell>2 (4.1%)</cell><cell>11 (22.4%)</cell></row><row><cell>Germany</cell><cell>163</cell><cell>25 5 / 7 -28 3 / 7 26 6 / 7</cell><cell>720-1,060 916</cell><cell>5 (3.1%)</cell><cell>12 (7.4%)</cell></row><row><cell>Israel</cell><cell>71</cell><cell>26 4 / 7 -29 0 / 7 27 4 / 7</cell><cell>870-1,120 980</cell><cell>0 (0.0%)</cell><cell>10 (14.1%)</cell></row><row><cell>The Netherlands</cell><cell>106</cell><cell>25 5 / 7 -28 1 / 7 27 0 / 7</cell><cell>748-1,021 888</cell><cell>12 (11.3%)</cell><cell>7 (6.6%)</cell></row><row><cell>Norway</cell><cell>24</cell><cell>25 5 / 7 -28 6 / 7 27 2 / 7</cell><cell>785-1,229 921</cell><cell>0 (0.0%)</cell><cell>2 (8.3%)</cell></row><row><cell>Turkey</cell><cell>118</cell><cell>27 3 / 7 -29 4 / 7 28 6 / 7</cell><cell>959-1,290 1,135</cell><cell>5 (4.2%)</cell><cell>14 (11.9%)</cell></row><row><cell>United Kingdom</cell><cell>265</cell><cell>26 0 / 7 -28 6 / 7 27 2 / 7</cell><cell>772-1,164 920</cell><cell>6 (2.3%)</cell><cell>34 (12.8%)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>Urinary NTproBNP concentrations and UNBCR in survivors without ROP requiring treatment, survivors who had severe ROP requiring treatment (laser or intravitreal injection), and infants who died</s></p></div></figDesc><table><row><cell cols="2">Survivors, no ROP</cell><cell>Survivors, ROP</cell><cell>Died</cell><cell>P</cell></row><row><cell cols="2">treatment</cell><cell>treatment</cell><cell>(n = 36)</cell><cell></cell></row><row><cell cols="2">(n = 837)</cell><cell>(n = 94)</cell><cell></cell><cell></cell></row><row><cell>NTproBNP (pg/ml)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>DOL14</cell><cell>816</cell><cell>3,083</cell><cell>8,950</cell><cell>o0.001</cell></row><row><cell cols="2">290-3,078</cell><cell>1,193-17,393</cell><cell>1,925-23,783</cell><cell></cell></row><row><cell>DOL28</cell><cell>408</cell><cell>1,671</cell><cell>2,203</cell><cell>o0.001</cell></row><row><cell cols="2">162-1,126</cell><cell>254-11,340</cell><cell>611-4,063</cell><cell></cell></row><row><cell>UNBCR (×10 − 4 )</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>DOL14</cell><cell>76</cell><cell>494</cell><cell>971</cell><cell>o0.001</cell></row><row><cell cols="2">26-297</cell><cell>106-2,064</cell><cell>142-2,359</cell><cell></cell></row><row><cell>DOL28</cell><cell>34</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">14-99</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 3 .</head><label>3</label><figDesc><div><p><s>Urinary NTproBNP concentrations and UNBCR in preterm infants with various stages of ROP (median, interquartile range)</s></p></div></figDesc><table><row><cell></cell><cell>No ROP</cell><cell>ROP 1</cell><cell>ROP 2</cell><cell>ROP 3</cell><cell>P</cell></row><row><cell cols="2">NTproBNP (pg/ml)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>DOL14</cell><cell>634</cell><cell>796</cell><cell>1,929</cell><cell>3,614</cell><cell>o0.001</cell></row><row><cell></cell><cell>248-2,187</cell><cell>325-2,537</cell><cell>700-8,502</cell><cell>1,109-15,619</cell><cell></cell></row><row><cell>DOL28</cell><cell>340</cell><cell>417</cell><cell>856</cell><cell>1,956</cell><cell>o0.001</cell></row><row><cell></cell><cell>144-746</cell><cell>168-1,566</cell><cell>271-2,545</cell><cell>502-11,884</cell><cell></cell></row><row><cell cols="2">UNBCR (×10 − 4 )</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>DOL14</cell><cell>60</cell><cell>79</cell><cell>176</cell><cell>514</cell><cell>o0.001</cell></row><row><cell></cell><cell>22-191</cell><cell>29-283</cell><cell>59-1,000</cell><cell>108-2,045</cell><cell></cell></row><row><cell>DOL28</cell><cell>30</cell><cell>35</cell><cell>82</cell><cell>208</cell><cell>o0.001</cell></row><row><cell></cell><cell>11-69</cell><cell>16-122</cell><cell>24-272</cell><cell>34-1,446</cell><cell></cell></row><row><cell cols="6">DOL, day of living; NTproBNP, N-terminal B-type natriuretic peptide; ROP, retino-</cell></row><row><cell cols="5">pathy of prematurity; UNBCR, urinary NTproBNP/creatinine ratio.</cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 4 .</head><label>4</label><figDesc><div><p><s>Areas under ROC curves to predict survival without ROP treatment</s></p></div></figDesc><table><row><cell>Variable</cell><cell>Area</cell><cell>95% CI</cell><cell>P</cell></row><row><cell>NTproBNP</cell><cell></cell><cell></cell><cell></cell></row><row><cell>DOL14</cell><cell>0.731</cell><cell>0.686-0.777</cell><cell>o0.001</cell></row><row><cell>DOL28</cell><cell>0.683</cell><cell>0.622-0.745</cell><cell>o0.001</cell></row><row><cell>UNBCR</cell><cell></cell><cell></cell><cell></cell></row><row><cell>DOL14</cell><cell>0.762</cell><cell>0.720-0.805</cell><cell>o0.001</cell></row><row><cell>DOL28</cell><cell>0.701</cell><cell>0.641-0.762</cell><cell>o0.001</cell></row><row><cell>Birth weight</cell><cell>0.743</cell><cell>0.699-0.787</cell><cell>o0.001</cell></row><row><cell>Gestational age</cell><cell>0.792</cell><cell>0.682-0.777</cell><cell>o0.001</cell></row><row><cell>Proportional weight</cell><cell>0.570</cell><cell>0.509-0.631</cell><cell>0.016</cell></row><row><cell>gain</cell><cell></cell><cell></cell><cell></cell></row><row><cell>from birth to DOL28</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Score DOL14</cell><cell>0.745</cell><cell>0.703-0.787</cell><cell>o0.001</cell></row><row><cell>Score DOL28</cell><cell>0.739</cell><cell>0.687-0.791</cell><cell>o0.001</cell></row><row><cell cols="4">CI, confidence interval; DOL, day of life; NTproBNP, N-terminal B-type natriuretic</cell></row><row><cell cols="4">peptide; ROC, receiver operating characteristics; ROP, retinopathy of prematurity;</cell></row><row><cell cols="2">UNBCR, urinary NTproBNP/creatinine ratio.</cell><cell></cell><cell></cell></row><row><cell cols="4">Score DOL14: 300-0.156 × gestational age (weeks) − 0.118 × birth weight (g)</cell></row><row><cell>+0.146 × NTproBNP DOL14 (pg/ml).</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="4">Score DOL28: 300 − 0.118 × gestational age (weeks) − 0.131 × birth weight (g)</cell></row><row><cell cols="4">+0.067 × NTproBNP DOL14 (pg/ml)+0.180 × NTproBNP DOL28 (pg/ml) − 0.110 ×</cell></row><row><cell cols="2">proportional weight gain birth to DOL 28 (fraction).</cell><cell></cell><cell></cell></row></table></figure>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>STATEMENT OF FINANCIAL SUPPORT</head><p><s>The study has received financial support from the BLISS innovation grant (London, UK) and intramural funding.</s></p><p><s>Disclosure: The authors declare no conflict of interest.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Zivanit Ergaz-Shaltiel</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">20</biblScope>
		</imprint>
	</monogr>
	<note>Thomas Skeath</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Hadassah Medical Center</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
		</imprint>
		<respStmt>
			<orgName>Department of Pediatrics and Adolescent Medicine, Medical University of Vienna</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Royal Victoria Infirmary</title>
	</analytic>
	<monogr>
		<title level="m">Zekai Tahir Burak Maternity Hospital</title>
				<meeting><address><addrLine>Berlin, Germany; Ankara, Turkey; Newcastle upon Tyne, UK; Leuven, Belgium; Amsterdam, The Netherlands</addrLine></address></meeting>
		<imprint>
			<biblScope unit="volume">15</biblScope>
		</imprint>
		<respStmt>
			<orgName>Charité Universitätsmedizin Berlin ; Department of Development and Regeneration, Catholic University of Leuven</orgName>
		</respStmt>
	</monogr>
	<note>Emma Children&apos;s Hospital</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Pretermassociated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010</title>
		<author>
			<persName><forename type="first">H</forename><surname>References 1. Blencowe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Lawn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Vazquez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fielder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gilbert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Res</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="35" to="49" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Telemedicine for evaluation of retinopathy of prematurity</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Fierson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Capone</surname><genName>Jr</genName></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">American Academy of Pediatrics Section on Opthalmology, American Academy of Ophthalmology</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="e238" to="e254" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>Pediatrics</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Limitations in ROP programs in 32 neonatal intensive care units in five states in Mexico</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Zepeda-Romero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gilbert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomed Res Int</title>
		<imprint>
			<biblScope unit="page">712624</biblScope>
			<date type="published" when="2015">2015. 2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Impact of improved neonatal care on the profile of retinopathy of prematurity in rural neonatal centers in India over a 4-year period</title>
		<author>
			<persName><forename type="first">A</forename><surname>Vinekar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Jayadev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kumar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eye Brain</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="45" to="53" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Systemic manifestations in response to mydriasis and physical examination during screening for retinopathy of prematurity</title>
		<author>
			<persName><forename type="first">R</forename><surname>Rush</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rush</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nicolau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Chapman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Naqvi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Retina</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="242" to="245" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Pain in neonates during screening for retinopathy of prematurity using binocular indirect ophthalmoscopy and wide-field digital retinal imaging: a randomised comparison</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Dhaliwal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mcintosh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Dhaliwal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Fleck</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Dis Child Fetal Neonatal Ed</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="F146" to="148" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Widespread retinal hemorrhages after retinopathy of prematurity screening with scleral depression</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Forbes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Prieto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Binenbaum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J AAPOS</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="609" to="611" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">The pain response to mydriatic eyedrops in preterm infants</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Cook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Ying</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Binenbaum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Perinatol</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="462" to="465" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Safety of retinopathy of prematurity examination and imaging in premature infants</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Wade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pistilli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Baumritter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pediatr</title>
		<imprint>
			<biblScope unit="volume">167</biblScope>
			<biblScope unit="page">e1002</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Retinopathy of prematurity screening leading to cardiopulmonary arrest: fatal complication of a benign procedure</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Agrawal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Patri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Kalavakunta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Gupta</surname></persName>
		</author>
		<idno>pii: bcr2016216594</idno>
	</analytic>
	<monogr>
		<title level="j">Br Med J</title>
		<imprint>
			<date type="published" when="2016">2016. 2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Can oral sucrose reduce the pain and distress associated with screening for retinopathy of prematurity?</title>
		<author>
			<persName><forename type="first">J</forename><surname>Grabska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Walden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lerer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Perinatol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="33" to="35" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Clinical value of NT-ProBNP and BNP in pediatric cardiology</title>
		<author>
			<persName><forename type="first">A</forename><surname>Nir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Nasser</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Card Fail</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="S76" to="80" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">The role of N-terminal pro-Btype natriuretic peptide in the diagnosis of congestive heart failure in children. -Correlation with the heart failure score and comparison with B-type natriuretic peptide</title>
		<author>
			<persName><forename type="first">M</forename><surname>Sugimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Manabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Nakau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ J</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="page" from="998" to="1005" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Amino terminal pro B-type natriuretic peptide levels are elevated in the cord blood of neonates with congenital heart defect</title>
		<author>
			<persName><forename type="first">E</forename><surname>Lechner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wiesinger-Eidenberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Wagner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Res</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="466" to="469" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Usefulness of measurement of urinary N-terminal pro-brain natriuretic peptide in neonatal period</title>
		<author>
			<persName><forename type="first">N</forename><surname>Kurihara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Miwa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Matsuzaki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Int</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page">608</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Diagnosing significant PDA using natriuretic peptides in preterm neonates: a systematic review</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kulkarni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gokulakrishnan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Fernandes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Leeflang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pammi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatrics</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="e510" to="525" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Urinary N-terminal B-type natriuretic peptide predicts severe retinopathy of prematurity</title>
		<author>
			<persName><forename type="first">C</forename><surname>Czernik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Metze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Müller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Müller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bührer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatrics</title>
		<imprint>
			<biblScope unit="volume">128</biblScope>
			<biblScope unit="page" from="e545" to="549" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited</title>
	</analytic>
	<monogr>
		<title level="j">Arch Ophthalmol</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="991" to="999" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial</title>
	</analytic>
	<monogr>
		<title level="j">Arch Ophthalmol</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="1684" to="1694" />
			<date type="published" when="2003">2003</date>
		</imprint>
		<respStmt>
			<orgName>Early Treatment For Retinopathy Of Prematurity Cooperative Group</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Validation of WINROP for detecting retinopathy of prematurity in a North American cohort of preterm infants</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Mccourt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J AAPOS</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="229" to="233" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">A tiered approach to retinopathy of prematurity acreening (TARP) using a weight gain predictive model and a telemedicine system</title>
		<author>
			<persName><forename type="first">J</forename><surname>Gurwin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Tomlinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Quinn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA Ophthalmol</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="131" to="136" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Reduction in screening for retinopathy of prematurity through risk factor adjusted inclusion criteria</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Van Sorge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">E</forename><surname>Schalij-Delfos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">T</forename><surname>Kerkhoff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Ophthalmol</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="1143" to="1147" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Retinopathy of prematurity: risk factors and variability in Canadian neonatal intensive care units</title>
		<author>
			<persName><forename type="first">K</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Canning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Harrison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Dow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neonatal Perinatal Med</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="207" to="214" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Neonatal risk factors for treatment-demanding retinopathy of prematurity: a Danish national study</title>
		<author>
			<persName><forename type="first">C</forename><surname>Slidsborg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Forman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ophthalmology</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="796" to="803" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Nationwide inventory of risk factors for retinopathy of prematurity in the Netherlands</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Van Sorge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">U</forename><surname>Termote</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">T</forename><surname>Kerkhoff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pediatr</title>
		<imprint>
			<biblScope unit="volume">164</biblScope>
			<biblScope unit="page" from="494" to="498" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Dopamine is an indicator but not an independent risk factor for grade 3 retinopathy of prematurity in extreme low birthweight infants</title>
		<author>
			<persName><forename type="first">K</forename><surname>Allegaert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Cossey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Naulaers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Vanhole</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Devlieger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Casteels</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Ophthalmol</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="309" to="310" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Dopamine-resistant hypotension and severe retinopathy of prematurity</title>
		<author>
			<persName><forename type="first">M</forename><surname>Catenacci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Miyagi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Wickremasinghe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pediatr</title>
		<imprint>
			<biblScope unit="volume">163</biblScope>
			<biblScope unit="page" from="400" to="405" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Preclinical screening for retinopathy of prematurity risk using IGF1 levels at 3 weeks post-partum</title>
		<author>
			<persName><forename type="first">A</forename><surname>Perez-Muñuzuri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Couce-Pico</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Baña-Souto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">e88781</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Evaluating the association of autonomic drug use to the development and severity of retinopathy of prematurity</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Hussein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Coats</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Khan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J AAPOS</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="332" to="337" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Brueckmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Huhle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="527" to="534" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock</title>
		<author>
			<persName><forename type="first">M</forename><surname>Varpula</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Pulkki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Karlsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ruokonen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Pettila</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="1277" to="1283" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Biological serum markers in the management of pediatric pulmonary arterial hypertension</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Van Albada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">G</forename><surname>Loot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Fokkema</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Roofthooft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Berger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Res</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="321" to="327" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">N-terminal pro-brain natriuretic peptide is a useful diagnostic marker for transfusionassociated circulatory overload</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Tobian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Sokoll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Tisch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Ness</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Shan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Transfusion</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="1143" to="1150" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Hypoxic conditions stimulate the release of B-type natriuretic peptide from human retinal pigment epithelium cell culture</title>
		<author>
			<persName><forename type="first">V</forename><surname>Aaltonen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kinnunen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Jouhilahti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Ophthalmol</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="740" to="744" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">The cellular expression of antiangiogenic factors in fetal primate macula</title>
		<author>
			<persName><forename type="first">P</forename><surname>Kozulin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Natoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Bumsted</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Brien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Madigan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Provis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Invest Ophthalmol Vis Sci</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="4298" to="4306" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Do cardiac biomarkers NT-proBNP and hsTnT predict microvascular events in patients with type 2 diabetes? Results from the ADVANCE trial</title>
		<author>
			<persName><forename type="first">P</forename><surname>Welsh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Woodward</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Hillis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="2202" to="2210" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Nterminal pro-B-type natriuretic peptide is related to retinal microvascular damage: the Rotterdam study</title>
		<author>
			<persName><forename type="first">U</forename><surname>Mutlu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Ikram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hofman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>De Jong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Klaver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Ikram</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arterioscler Thromb Vasc Biol</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="1698" to="1702" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes</title>
		<author>
			<persName><forename type="first">K</forename><surname>Hamano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Nakadaira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gonai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Vasc Health Risk Manag</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="585" to="589" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">International variations and trends in the treatment for retinopathy of prematurity</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Darlow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kusuda</surname></persName>
		</author>
		<idno type="DOI">10.1136/bjophthalmol-2016-310041</idno>
	</analytic>
	<monogr>
		<title level="j">Br J Ophthalmol</title>
		<imprint>
			<date type="published" when="2017-03">2017. March 2017</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
